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Associations of Subjective Sleep Quality and Daytime Sleepiness with
Cognitive Impairment in Adults and Elders with Heart Failure
Abstract
This study examined the association of subjective nighttime sleep quality and daytime sleepiness with
cognitive impairment in 105 adults (< 60 years old) and 167 elders (≥ 60 years old) with heart failure.
Nighttime sleep quality and daytime sleepiness were measured by the Pittsburgh Sleep Quality Index and the
Epworth Sleepiness Scale. Cognitive impairment was assessed using a neuropsychological battery measuring
attention, memory, and processing speed. Multivariate logistic regression was used. In adults, daytime
sleepiness was associated with cognitive impairment, whereas poor nighttime sleep quality was associated
with cognitive impairment in elders. Age may play an important role in how sleep impacts cognition in
persons with heart failure. Improving nighttime sleep quality and daytime sleepiness in this population may
improve cognition.
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Associations of Subjective Sleep Quality and Daytime Sleepiness with  
Cognitive Impairment in Adults and Elders with Heart Failure 
Abstract 
This study examined the association of subjective nighttime sleep quality and daytime sleepiness 
with cognitive impairment in 105 adults (< 60 years old) and 167 elders (≥ 60 years old) with 
heart failure. Nighttime sleep quality and daytime sleepiness were measured by the Pittsburgh 
Sleep Quality Index and the Epworth Sleepiness Scale. Cognitive impairment was assessed using 
a neuropsychological battery measuring attention, memory and processing speed. Multivariate 
logistic regression was used. In adults, daytime sleepiness was associated with cognitive 
impairment, whereas poor nighttime sleep quality was associated with cognitive impairment in 
elders. Age may play an important role how sleep impacts cognition in persons with heart failure. 
Improving nighttime sleep quality and daytime sleepiness in this population may improve 
cognition.  
 
  
Introduction 
Heart failure (HF) is one of the most prevalent chronic conditions in developed and 
developing countries; in the United States, heart failure affects approximately 5.7 million people 
(Mozaffarian et al., 2015). Cognitive impairment, such as memory loss, attention deficit and 
slow processing speed, are common in persons with HF (Gure et al., 2012; Pressler et al., 2010). 
Approximately 25–50% of persons with HF test positively with evidence of cognitive 
impairment (Pressler, 2008; Staniforth, Kinnear, & Cowley, 2001). Despite a burgeoning 
literature on the topic, the underlying mechanisms remain unclear. In HF, disease severity, 
microemboli, and cerebral hypoperfusion are thought to contribute to cognitive impairment 
(Heckman et al., 2007; Jesus et al., 2006; Staniforth et al., 2001). Older age is also recognized as 
a contributor (Heckman et al., 2007). Specifically, elders with HF are more likely to have 
cognitive impairment compared to elders without HF (Qiu et al., 2006; Tilvis et al., 2004), 
suggesting that both processes of aging and HF contribute to cognitive impairment in this 
population. In elders with HF, cognitive impairment has been related to the severity of HF 
symptoms and in particular to left ventricular systolic dysfunction (Heckman et al., 2007). 
Sleep disturbances are also common in individuals with HF, with 35–70% complaining 
of this problem (Broström, Strömberg, Dahlström, & Fridlund, 2004; Chen & Clark, 2007; 
Erickson, Westlake, Dracup, Woo, & Hage, 2003). Sleep disturbances in HF are related to 
symptoms such as fatigue, depression, and daytime sleepiness (Redeker, 2008). Chen et al. 
(2010) reported that poor nighttime sleep quality is associated with poor health-related quality of 
life in HF (Chen, Clark, Tsai, & Lin, 2010). Heart failure patients with daytime sleepiness are 
more likely to have poor medication adherence than those without daytime sleepiness (Knafl & 
Riegel, 2014; Riegel et al., 2011), which can lead to unplanned hospitalization (Riegel & Knafl,  
  
2013).  
Both HF and cognitive impairment increase the risk of early mortality. Cognitive 
impairment is known to be related to poor self-care (Bauer et al., 2012; Dickson, Tkacs, & 
Riegel, 2007). It may be that mortality is higher when patients are unable to recognize worsening 
HF symptoms or manage their complex medical regimens. If sleep disturbance is related to 
cognitive impairment in HF, improving sleep may improve cognitive function, which may 
improve self-care and symptom management in these patients.  
The extent to which characteristics of sleep are associated with cognitive impairment in 
HF is not well studied. This relationship may differ in adults and elders with HF because of the 
overlay of age-related changes in cognition and sleep. A meta-analysis revealed that, in a healthy 
population, there are significant changes in sleep parameters (e.g., total sleep time, percentage of 
REM sleep) with age from early adulthood to age 60 years, but minimal decline in sleep patterns 
after age 60 years (Ohayon, Carskadon, Guilleminault, & Vitiello, 2004). However, others have 
reported that sleep disturbances and cognitive impairment are related to aging (Blackwell et al., 
2014; Heckman et al., 2007; Institute of Medicine, 2015). Elders with an acute (e.g. stroke) or 
chronic illness diagnosis (e.g. arthritis) often report sleep-related problems such as breathing 
pauses, snoring, daytime sleepiness, restless legs, or poor sleep quality (Newman, Enright, 
Manolio, Haponik, & Wahl, 1997). Thus, the purpose of the study was to examine the 
association of subjective nighttime sleep quality and daytime sleepiness with cognitive 
impairment in adults and elders with HF. We hypothesized that subjective nighttime sleep 
quality and daytime sleepiness would be worse in HF patients with cognitive impairment 
compared to HF patients without cognitive impairment and explored whether the associations 
would differ when age was taken into account.  
  
Methods 
This cross-sectional study was a secondary analysis of baseline data from a prospective 
longitudinal cohort study of adults with HF (Riegel et al., 2011). The purpose of the parent study 
was to test the hypothesis that adults with HF and excessive daytime sleepiness would, over time, 
experience more problems with self-care than those without excessive daytime sleepiness. The 
major finding of the parent study was that adults with HF and excessive daytime sleepiness 
demonstrated significantly higher medication nonadherence compared to those without excessive 
daytime sleepiness, regardless of cognitive status (Riegel et al., 2011). Patients were recruited 
from three outpatient settings in Philadelphia, Pennsylvania and Newark, Delaware. The study 
was approved by the Institutional Review Board from all recruitment sites and all participants 
provided written informed consent. To be included in the parent study, patients had to (a) have 
symptomatic HF confirmed by echocardiographic and clinical evidence, (b) be able to speak and 
read English for reliable cognition testing, and (c) have a score ≥ 24 on the Telephone Screen of 
Impaired Cognition scale, which indicates that the person is either cognitively intact or has mild 
cognitive impairment (Brandt & Folstein, 2003). Those with severe cognitive impairment such as 
dementia were excluded. Patients with major depression were excluded because of the known 
influence of depression on cognition (Van der Mussele et al., 2014). Patients described in the 
medical record as having major depression were not approached. Patients were screened with the 
Patient Health Questionnaire (Kroenke & Spitzer, 2002); those who reported ≥ 5 of the 9 
symptoms more than half the days in the past 2 weeks were excluded if one of the symptoms was 
depressed mood or anhedonia. Patients who lived in a long-term-care setting, worked night shift 
or rotating shifts, planned to move out of the area, or had renal failure requiring dialysis, a 
history of drug or alcohol abuse in the preceding year, or whose death was imminent were  
  
excluded based on the goals of the parent study. 
For the parent study, 333 patients with HF were eligible for inclusion and 280 were 
enrolled and followed for 6 months. Cognitive testing data were missing on 8 of these 
participants, so the present analysis included a total of 272 individuals. We divided participants 
into two age cohorts: 105 adults (< 60 years), 167 elders (≥ 60 years). 
Measurement 
Nighttime Sleep Quality 
The 19-item Pittsburgh Sleep Quality Index was used to measure nighttime sleep quality 
and types of sleep disturbances over the past month (Buysse, Reynolds, Monk, Berman, & 
Kupfer, 1989). This scale includes seven component scores: subjective sleep quality, sleep 
latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, 
and daytime dysfunction. Scores range from 0 to 21, with higher scores indicating poorer sleep 
quality. A global Pittsburgh Sleep Quality Index score > 5 is a sensitive and specific measure of 
poor sleep quality (Buysse et al., 1989). This scale has demonstrated good reliability and validity 
across many patient populations (Buysse et al., 1989). 
Daytime Sleepiness 
The 8-item Epworth Sleepiness Scale was used to assess the likelihood of falling asleep 
in common daily situations (Johns, 1992). Each item on a 4 point scale is summed with scores 
ranging 0 to 24, with higher scores indicating greater sleepiness. A cutoff point of  > 10 is 
considered sleepy (Johns, 1992). The scale has well established validity and reliability (Johns, 
1992). 
Sleep Disordered Breathing 
At enrollment, the medical record was reviewed and a physician diagnosis of sleep  
  
disordered breathing based on polysomnography was obtained. If documentation of recent sleep 
testing was not found in the medical record, sleep was assessed in the home using an unattended 
sleep study device, the Embletta (Medcare, Buffalo, New York, USA). Individuals with an apnea 
hypopnea index (AHI) ≥ 5 were classified as having sleep disordered breathing (Ruehland et al., 
2009). 
Cognitive Impairment 
Neuropsychological tests were administrated to assess the cognitive domains known to be 
influenced by sleep deprivation (Lim & Dinges, 2010). The test battery included the 
Psychomotor Vigilance Test (Basner & Dinges, 2011; Dinges et al., 1997; simple attention), the 
Trail Making Test B (Reitan, 1992; complex attention), the Digital Symbol-Substitution Test 
(The Psychological Corporation, 2002; processing speed), the Probed Memory Recall Test 
(Dinges, Kribbs, Bates, & Carlin, 1993; working memory), and the Letter Number Sequencing 
Test (The Psychological Corporation, 2002; short-term memory). Each measure in the 
Neuropsychological Battery is described in Table 1.  
The number of tests on which subjects scored below their norm was used as the measure 
of cognitive status. Specifically, participants scoring 1.5 standard deviations below the norm (Jak 
et al., 2009) on two or more of the five neuropsychological tests, the Psychomotor Vigilance Test, 
Trail Making Test B, Digital Symbol-Substitution Test, Probed Memory Recall Test, and Letter 
Number Sequencing Test, were classified as having cognitive impairment.  
Demographic and Clinical Characteristics 
Demographic characteristics such as age, gender, race, education, and income were 
collected. Education was categorized into one of three groups: less than high school, high school, 
or any college. In addition, the American National Adult Reading Test (ANART) was used to 
  
assess premorbid intellect (Gladsjo, Heaton, Palmer, Taylor, & Jeste, 1999). Participants were 
asked to read a list of 50 phonetically irregular words aloud. The number of words pronounced 
correctly was used in the analysis as a covariate. Participants were asked to rate their household 
income as: 1) comfortable, have more than enough to make ends meet; 2) having enough to 
make ends meet; or 3) not having enough to make ends meet. They were interviewed about the 
number of hours they typically slept at night. Clinical information such as months with HF, type 
of HF or HF etiology and left ventricular ejection fraction was collected from the medical record. 
A cardiologist scored the New York Heart Association (NYHA) functional class (class I is 
without symptoms, class II is symptoms with exertion, class III is symptoms with any physical 
activity, and class IV is symptoms at rest), which was used as a measure of HF severity (Raphael 
et al., 2007). Comorbidity was assessed using the Charlson Index, with higher scores indicating 
more comorbid illnesses (Charlson, Pompei, Ales, & MacKenzie, 1987). Although those with 
major depression were excluded, as described above, depressive symptoms were assessed at each 
testing interval using the Patient Health Questionnaire-9 (Kroenke & Spitzer, 2002). Total scores 
range from 0 to 24, with severity classified as none (score 1 to 4), mild (5 to 9), moderate (10 to 
14), moderately severe (15 to 19) and severe (20 to 27) depression (Kroenke & Spitzer, 2002).  
Statistical Analysis 
Measures of central tendency were used to describe demographic and clinical 
characteristics. Differences between adults and elders were tested with independent sample t-
tests or Chi-square test of independence. Independent sample t-tests or Chi-square test of 
independence were also used to compare sleep characteristics of participants with and without 
cognitive impairment.   
Pearson correlation was used to explore relationships between subjective nighttime sleep  
  
quality, subjective daytime sleepiness and each cognitive test. Multivariate logistic regression 
was used to test the impact of nighttime sleep quality and daytime sleepiness on cognitive 
impairment. The Probed Memory Recall Test is influenced by age and gender (Kim, Dinges, & 
Young, 2007), so age and gender were adjusted in the analysis as were race, years of education, 
premorbid intellect, severity of HF, comorbidity, depression and recruitment site. The model was 
tested twice: adults (< 60 years of age) and elders (≥ 60 years of age). In addition, we controlled 
for age as a continuous variable in each of these analyses. For all analyses, p < .05 in a two-sided 
test was considered statistically significant. All analyses were performed using SPSS version 22 
software for Windows (IBM Corporation, Armonk, NY).  
Results 
Demographic and clinical characteristics for the sample of 272 individuals (105 adults 
[< 60 years of age] and 167 elders [≥ 60 years of age]) are shown in Table 2. Most were White 
males who were functionally compromised. The mean ages for the adults and elders were 50.0 (± 
7.7, range 24 – 59, median 51) and 69.8 (± 7.4, range 60 – 89, median 68), respectively. Sleep 
characteristics and statistical differences (p values) between participants with and without 
cognitive impairment are shown in Table 3. Total sleep times were below 8 hours per night. 
Most of the sample had poor sleep quality but daytime sleepiness was not high in most. More 
than half of the sample had sleep disordered breathing. In those with an apnea hypopnea index 
available (only 25% in adults and 23% in elders), 38% of adults and 63% of elders had an AHI ≥ 
5. A summary of the cognitive measures is shown in Table 4. The prevalence of cognitive 
impairment was 32% in adults and 44% in elders. 
The relationships between scores on the Pittsburgh Sleep Quality Index, the Epworth 
Sleepiness Scale, and each cognition test are shown in Table 5. Poorer subjective nighttime sleep 
  
quality was positively associated with more daytime sleepiness (r = 0.384, p < .001 in adults; r = 
0.160, p = .038 in elders). In adults, with the exception of the digit symbol-substitution test, more 
daytime sleepiness was significantly associated with poorer performance in each cognitive test. 
In elders, poorer nighttime sleep quality was significantly associated with worse performance on 
each cognitive test.  
In adults, each additional one unit increase in daytime sleepiness increased the odds of 
cognitive impairment by 25% (Odds Ratio [OR] 1.25, 95% Confidence Interval [CI] 1.08–1.45, 
p = .003, see Table 6). Each additional one unit increase in premorbid intellect decreased the 
odds of cognitive impairment by 11% (OR .89, 95% CI .83–.96, p = .001). In elders, each 
additional one unit increase in poor nighttime sleep quality increased the odds of cognitive 
impairment by 16% (OR 1.16, 95% CI 1.03–1.31, p = .017). For each additional year in age, the 
odds of cognitive impairment increased by 8% (OR = 1.08, 95% CI 1.01–1.14, p = .015). There 
was a statistical difference in cognitive impairment between sites.    
Discussion 
The major finding from our study was that in both age groups, the prevalence of 
cognitive impairment was high, and sleep variables were associated with cognition. The majority 
of participants had poor sleep quality and approximately one third in each age group had 
excessive daytime sleepiness. Specifically, in elders with HF, poor subjective nighttime sleep 
quality was significantly associated with cognitive impairment after adjusting for covariates. In 
adults younger than 60 years, subjective excessive daytime sleepiness was associated with worse 
cognitive performance. Another factor influencing cognitive impairment in the adults was 
premorbid intellect. In the elders, older age was positively associated with cognitive impairment.  
Our findings are similar to those of Garcia et al. (2012) who reported a significant  
  
association of poorer sleep quality with reduced performance on tests of attention/executive 
function, with a trend for memory but not language in elders with HF. Their sample included 
individuals between 50 and 85 years of age and they controlled for age in the analyses. Our 
results are more nuanced because we divided our sample into two separate age groups for 
analysis and revealed different sleep characteristics in each group associated with cognitive 
impairment: daytime sleepiness in the adults and nighttime sleep quality in the elders. We also 
assessed cognitive status using a rigorous neuropsychological battery of tests measuring the 
major cognitive domains influenced by sleep loss and we confirmed that night time sleep quality 
was associated with cognitive impairment in elders. Using this neuropsychological battery 
allowed us to identify subtle relationships between sleep and cognition that others have not 
previously identified: associations of more daytime sleepiness with poorer performance in the 
majority of the cognitive tests in the adults and associations of poorer nighttime sleep quality 
with worse performance on each cognitive test in the elders.  
One possible mechanism of cognitive impairment in HF is cerebral hypoperfusion 
(Heckman et al., 2007; Staniforth et al., 2001). Heart failure causes hypoperfusion due to an 
inability of the heart to pump adequately to perfuse the brain. In addition, impaired sleep has 
been related to decreased cerebral flow in the right and left frontal lobes (Miyata et al., 2010). If 
impaired sleep aggravates cerebral hypoperfusion in HF, it could contribute to other factors 
causing cognitive impairment (Garcia et al., 2012). Another plausible mechanism is that sleep 
disturbances impair memory consolidation and restoration of brain function during the night 
(Jelicic et al., 2002; Sterniczuk, Theou, Rusak, & Rockwood, 2013). Experimental models of 
total or partial sleep deprivation suggest that poor sleep might contribute to cognitive impairment 
by promoting neuroinflammation or changing neuronal morphology in the prefrontal or 
  
hippocampus areas that regulate learning and memory processes (Acosta-peña et al., 2015; Zhu 
et al., 2012). Susceptibility of the specific brain area to sleep deprivation has been seen by 
regional brain-activation studies using positron-emission tomography (PET) and functional 
magnetic resonance imaging (fMRI) (Thomas et al., 2000; Wu et al., 1991). Metabolic 
fluctuations in the prefrontal cortex and phasic electroencephalography (EEG) changes 
associated with alertness and attention in sleep deprivation might be related to cognitive 
impairment.  
The majority of previous experimental studies examined the effect of acute sleep 
deprivation. However, recent studies suggest that chronic partial sleep deprivation (3 days to 2 
weeks) decreases attention, memory, and cognitive speed or accuracy (Drake et al., 2001; Van 
Dongen, Maislin, Mullington, & Dinges, 2003). Information regarding neurocognitive 
consequences of self-reported sleep quality is still lacking. Further research in a larger cohort of 
HF with longitudinal follow up is required to clarify mechanisms of the relationship between 
nighttime sleep quality, excessive daytime sleepiness, and cognitive impairment. 
In patients with HF, sleep problems are common and closely related to symptoms and 
prognosis. In HF patients, sleep problems have been associated with fatigue, weakness, and 
irregular heartbeats, mediated by hyperarousal, sympathetic activation, impaired immune-system 
functioning, and stimulation of the hypothalamic pituitary adrenal axis (Redeker, 2008). Redeker 
and Stein (2006) reported that patients diagnosed with systolic HF complained more of 
prolonged sleep latency, frequent sleep wakening during the night, and early morning awakening, 
compared with a non-HF control group. Some researchers reported between 21% and 44% of HF 
patients had excessive daytime sleepiness, which was higher than that of those without HF 
(Broström et al., 2004; Redeker & Stein, 2006). Others reported that patients with both HF and 
  
obstructive sleep apnea had less subjective daytime sleepiness compared with a community 
dwelling sample (Somers et al., 2008). Despite the lack of subjective perception of excessive 
daytime sleepiness, in individuals with HF and sleep-disordered breathing there was evidence of 
objective sleepiness (Arzt et al., 2006; Rao et al., 2006). Lack of sleepiness in HF may be due to 
autonomic stimulation (Aggarwal et al., 2002; Arzt et al., 2006; MacDonald, Fang, Pittman, 
White, & Malhotra, 2008; Rao et al., 2006), but further research is warranted to understand why 
individuals with HF do not complain of daytime sleepiness.  
It is not clear why excessive daytime sleepiness was associated with cognitive 
impairment only in the adults in our study, whereas nighttime sleep quality was associated with 
cognitive impairment in the elders with HF. These results are consistent with a prior study in 
which an association was found between excessive daytime sleepiness and napping in adults, but 
no association of excessive daytime sleepiness with napping in elders (Ohayon & Vecchierini, 
2002). It may be that adults are more sensitive to somatic input and sleep drive than elders 
(Khalsa, Rudrauf, & Tranel, 2009). It is also possible that adults are more likely to be working 
and experiencing sleepiness during normal activities, but feel that they cannot nap due to work 
responsibilities (Ohayon & Vecchierini, 2002).  
In elders, nighttime sleep quality was associated with cognitive impairment, as others 
have noted in elders with HF (Garcia et al., 2012) and in a community sample of elders 
(Blackwell et al., 2014; Nebes, Buysse, Halligan, Houck, & Monk, 2009). Some investigators 
have reported that, in community-dwelling elders, daytime sleepiness was associated with 
cognitive impairment (Foley et al., 2001; Ohayon & Vecchierini, 2002), but another study 
reported no association with cognitive impairment (Blackwell et al., 2014). Further research is 
needed to clarify the relationships between age, sleep, and cognition. 
  
Major limitations of this study are the cross-sectional analysis and the lack of objective 
sleep measures. In our secondary analysis, AHI was available only in one quarter of the subjects 
and it was not associated with cognitive impairment. Further research with objective sleep 
measures such as actigraphy or polysomnography are required to gain a better understanding of 
sleep disturbances in this population. Another limitation is the exclusion of severely cognitively 
impaired patients. It is plausible that people with severe cognitive impairment have more sleep 
disturbances and more daytime sleepiness than our sample. We also did not include a control 
group without HF, which would have expanded our understanding of these results. Individuals 
with HF may have increased risk of sleep disturbances and cognitive impairment than those 
without HF. Associations between sleep and cognition may also have been stronger in the HF 
group than those in a control group. Strengths of this study include the separate analysis of adults 
and elders, given that aging is closely related to cognitive function, use of a rigorous 
neuropsychological battery, and a large proportion of minority group participants. 
In summary, we found that more daytime sleepiness was associated with cognitive 
impairment in adults with HF. In addition, poor nighttime sleep quality was associated with 
cognitive impairment in elders with HF. Improving nighttime sleep quality and daytime 
sleepiness may improve cognition in this population. 
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 Table 1 
Description of Each Measure in the Neuropsychological Battery 
Cognitive Domain Neuropsychologic 
Test 
Brief Description of the Task 
Simple Attention Psychomotor 
Vigilance Task  
The Psychomotor Vigilance Test (Basner & Dinges, 2011; Dinges et 
al., 1997) was used to assess simple attention. Participants were asked 
to respond as rapidly as possible to a series of red digits “000” of light 
over a 10-minute period. Lapses, the number of times the participant 
failed to respond to the signal or failed to respond in a timely manner, 
were considered as problems with attention and psychomotor speed. 
Transformed lapses ≥ 4.69 were classified as abnormally high and an 
indicator of poor attention.  
Complex 
Attention 
Trail-Making Test B  The Trail-Making Test B (Reitan, 1992) was used to assess complex 
attention. Participants were asked to draw lines to connect circles that 
included both numbers and letters in serial order by alternating 
between the numbers and letters. The number of seconds required to 
complete the task, with higher scores indicating greater impairment, 
was used in the analysis. Age-specific norms were used to determine 
participants with or without impairment (Reitan, 1992).  
Processing Speed Digit Symbol-
Substitution Test  
 
The Digit Symbol-Substitution Test (The Psychological Corporation, 
2002) was used to assess processing speed. Participants were provided 
a pair of each unique number and different nonsense symbol. They 
were asked to transcribe the corresponding symbol for each paired 
number. The number correctly transcribed in 120 seconds was 
assessed. Age-specific norms were used to determine participants with 
and without impairment (The Psychological Corporation, 2002)  .  
Working Memory Probed-Memory 
Recall Task  
 
The Probed Memory Recall (Dinges et al., 1993) was used to assess 
working memory. Participants were shown a list of 4 word pairs for 30 
seconds. Then they were tested on other topics for 10 minutes. Next, 
participants were provided a list of 1 word in each pair with different 
order and asked to recall all 4 of the paired words within 1 minute. 
Participants recalling ≤ 1 word were considered impaired (Dinges et 
al., 1993).  
Short-term 
memory 
Letter Number 
Sequencing Subtest  
The Letter Number Sequencing subtest (The Psychological 
Corporation, 2002) was used to assess short-term memory. Participants 
were asked to read a sequence of numbers and letters in a specified 
random order. Then, they were asked to recall the numbers in 
ascending order and the letters in alphabetical order. The number of 
correctly recalled sequences was counted and age-adjusted scores were 
used (The Psychological Corporation, 2002). 
 
 
 
 
 
 
 
 
 
 
  
Table 2 
Demographic and Clinical Characteristics 
 Adults (N = 105)  Elders (N = 167)  
Characteristics 
Mean (SD) 
or N (%) 
 Mean (SD) 
or N (%) p value 
Demographic Characteristics      
Age 50.0 ± 7.74  69.8 ± 7.42 < .001 
Gender    .049 
Male 60 (57%)  115 (69%)  
Female 45 (43%)  52 (31%)  
Race    .056 
White 59 (56%)  113 (68%)  
Black/Others   46 (44%)  54 (32%)  
Education in Years  14.13 ± 2.68  13.76 ± 3.01 .300 
Education     .215 
Less than high school 6 (6%)  20 (12%)  
High school 38 (36%)  60 (36%)  
More than college  61 (58%)  87 (52%)  
American National Adult Reading Test 29.38 ± 12.68  30.52 ± 11.17 
(N = 166) 
.439 
Income     .112 
Have more than enough 29 (28%)  66 (40%)  
Have enough  55 (52%)  77 (46%)  
Do not have enough  21 (20%)  24 (14%)  
Clinical Characteristics      
Months with Heart Failure  76.97 ± 79.10 
(N  = 98) 
 70.36 ± 65.72 .472 
Heart Failure type 
    Systolic/Mixed 
    Diastolic 
 
83 (80%) 
21 (20%) 
(N = 104) 
  
137 (82%) 
30 (18%) 
.648 
Heart Failure Etiology  
    Ischemic 
    Nonischemic 
 
18 (17%) 
87 (83%) 
  
83 (50%) 
83 (50%) 
(N = 166) 
<.001 
Left Ventricular Ejection Fraction 36.54 ± 16.36  34.51 ± 17.27 .336 
NYHA    .091 
Class I or II 27 (26%)  37 (22%)  
Class III 53 (51%)  105 (63%)  
  
Class IV  25 (24%)  25 (15%)  
Total Number of Medications 8.90 ± 4.02  10.49 ± 3.80 .001 
Number of Medications Known to Cause 
Daytime Sleepiness 
1.50 ± .98  1.60 ± .98 .371 
Diuretic 81 (77%)  139 (83%) .214 
Beta-Blocker 98 (93%)  153 (92%) .606 
Comorbidity with the Charlson Comorbidity 
Index Score 
2.27 ± 1.32  3.05 ± 1.72 < .001 
Depression measured with the Patient Health 
Questionnaire (PHQ-9)  
5.12 ± 4.03  3.88 ± 3.31 .009 
Note. Comparison of groups via independent sample t-tests or Chi-square test of independence; NYHA = New York 
Heart Association.  
  
Table 3 
Summary for Sleep Characteristics  
 Adults (N = 105)  Elders (N = 167) 
 
               Characteristics 
Mean (SD) 
   or N (%) 
Range P value Mean (SD) 
    or N (%) 
Range P value 
Pittsburgh Sleep Quality Index (PSQI)        
    Global PSQI Total Score (0 – 21)  7.75 ± 4.16 1 – 17 .084  6.86 ± 3.96 0 – 19 .001 
    Good Sleeper (Global PSQI > 5) 21 (20%)  .833  53 (32%)  .012 
    Poor Sleeper (Global PSQI ≤ 5) 84 (80%)    114 (68%)   
 PSQI Subscales  
 (0= Worse, 3 =Better)  
       
    Sleep Latency  (0 – 3)  1.21 ± 1.08 0 – 3 .551  1.09 ± 0.86 0 – 3 .001 
    Sleep Duration  (0 – 3) 1.24 ± 0.96 0 – 3 .208  1.19 ± 0.99 0 – 3 .031 
    Habitual Sleep Efficiency (0 – 3) 1.05 ± 1.17 0 – 3 .131  0.94 ± 1.15 0 – 3 .006 
    Subjective Sleep Quality (0 – 3) 1.29 ± 0.74 0 – 3 .197  1.09 ± 0.86 0 – 3 .040 
    Sleep Disturbance (0 – 3) 1.36 ± 0.64 0 – 3 .757  1.20 ± .61 0 – 3 .453 
    Daytime Dysfunction (0 – 3) 1.08 ± 0.85 0 – 3 .110  0.71 ± 0.68 0 – 3 .248 
    Use of Sleeping Medication  (0 – 3) 0.53 ± 1.06 0 – 3 .249  0.69 ± 1.21 0 – 3 .517 
Epworth Sleeping Scale (ESS)         
    ESS Total Score (0 – 24)  7.76 ± 4.91 0 – 23 <.001  6.47 ± 4.33 0 – 21 .178 
    Sleepy (ESS > 10) 30 (29%)  <.001       36 (22%)  .134 
    Not Sleepy (ESS ≤ 10)    75 (71%)    131(78%)   
Total Sleep Time (hours)  6.26 ± 1.65 1 – 11 .305  6.34 ± 1.75  1 – 10 .291 
Sleep Disordered Breathing 55 (53%)  .471  94 (56%)   .076 
Apnea Hypopnea Index per hour  
    < 5 (No apnea) 
    ≥ 5 & <15 (Mild) 
    ≥15 & ≤ 30 (Moderate)  
    >30 (Severe)  
       N = 26 
16 (62%) 
5 (19%) 
4 (15%) 
1 (4%) 
 .488        N = 38 
14 (37%) 
10 (26%) 
9 (23%) 
5 (13%)  
 .999 
Note.  Independent sample t-tests or Chi-square test of independence were used to compare sleep characteristics of 
participants with and without cognitive impairment.   
 
 
 
 
 
  
Table 4 
Summary for Cognitive Tests 
   Adults (N = 105)  Elders (N = 167) 
Neuropsychologic 
Test 
 
Unit Normal 
Range 
Mean (SD) 
 
N (%) of 
Impaired 
Cognition 
 Mean (SD) 
  
N (%) of 
Impaired 
Cognition 
Psychomotor 
Vigilance Task 
(Basner & Dinges, 
2011; Dinges et 
al., 1997) 
Transformed 
Lapses 
< 4.69  4.55± 3.59 32 (31%)  5.31± 3.41† 75 (45%)† 
        
Trail-Making  
Test B (Reitan, 
1992) 
Time to 
complete, 
seconds 
Age-
specific 
norms 
87.19 ± 48.15 68 (65%)  125.85 ± 63.73 102 (61%) 
Digit Symbol-
Substitution Test 
(The 
Psychological 
Corporation,  
2002)  
Number 
correctly 
completed                         
in 120 
seconds 
Age-
specific 
norms 
61.09 ± 17.47 26 (25%)  48.53 ± 15.20 31 (19%) 
Probed-Memory 
Recall Task 
(Dinges et al., 
1993)  
Number of 
Words 
recalled 
> 1 of 4 
words 
          
2.49 ± 1.27 23 (22%)  1.75± 1.13 68 (41%) 
Letter Number 
Sequencing 
Subtest (The 
Psychological 
Corporation, 
2002)  
Number of 
correctly 
recalled 
sequences 
Age-
specific 
norms 
9.78 ± 3.26 11 (11%)  8.07 ± 3.48 33 (20%) 
Cognitive 
Impairment  
   33 (31%)   74 (44%)  
Note. N (%) of cognitively impaired participants for each cognitive test was based on the proportion of participants 
included in non-normal range; Final cognitive impairment was based on 1.5 standard deviations below norm on two 
or more of the five in neuropsychological tests; The American National Adult Reading Test was used as a covariate 
in analyses. †N=163 
 
 
 
  
Table 5  
Spearman correlation matrix of nighttime sleep quality and excessive daytime sleepiness with 
each cognitive test  
            Adults   (N = 105)                   Elders   (N = 167) 
 PSQI ESS  PSQI ESS 
Pittsburgh Sleep 
Quality Index 
(PSQI) 
     
Epworth Sleeping 
Scale (ESS) 
.384**   .160*  
Psychomotor 
Vigilance Task 
.397** .284**  .179*† .130† 
Trail-Making Test B .048 .198*  .224** -.017 
Digit Symbol-
Substitution Test 
-.095 -.087  -.244** .020 
Probed-Memory 
Recall Task 
.007 -.266**  -.212** .141 
Letter Number 
Sequencing Subtest 
-.190 -.232**  -.227** .072 
Note. *p < .05, **p < .01. † N = 163
  
Table 6 
Multivariate Logistic Regression Model for Cognitive Impairment  
 Adults (N = 105)  Elders (N = 166) 
Characteristics 
Odds ratio 95% CI p value  Odds ratio 95% CI p value 
Global PSQI .97 .81–1.18 .791  1.16 1.03–1.31 .017 
Epworth Sleeping Scale 1.25 1.08–1.45 .003  .92 0.83–1.02 .094 
Age  1.04 .97–1.12 .283  1.08 1.01–1.14 .015 
Gender        
Female  Reference       
Male  2.10 .59–7.43 .252  0.75 0.28–2.00 .569 
Race        
White Reference       
Black/Others  1.28 .35–4.67 .708  1.19 0.47–2.99 .713 
Education in Years  1.28 .96–1.71 .089  .95 0.80–1.11 .497 
ANART  .89 .83–.96 .001  .97 .93–1.01 .172 
NYHA        
Class IV  Reference       
Class I or II  1.54 .27–8.86 .629  .52 0.13–2.05 .352 
Class III .38 .09–1.56 .178  .33 0.10–1.05 .061 
Charlson Comorbidity 
Index Score 
1.05 0.64–1.72 .839  1.12 0.87–1.45 .366 
Patient Health 
Questionnaire  
1.07 0.90–1.28 .437  .960 0.83–1.11 .572 
Note. CI = Confidence Interval; PSQI = Pittsburgh Sleep Quality Index; ANART = American National Adult 
Reading Test; NYHA = New York Heart Association; The model was also adjusted for recruitment site; There was a 
statistical difference in cognitive impairment between sites in elders. 
